PCI-27483

PCI-27483 · Pharmacyclics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCI-27483, covering 2014-04-02 to 2014-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine [Phase 2]

See pricing